BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
1789 results:

  • 1. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
    Park J; An S; Bae JS; Kim JS; Kim K
    Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
    Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival.
    Yang L; Murthy S; Cortellini A; Lim EA; Gonzalez M; Pinato DJ; Abdel-Malek M; Mahmoud S; Martin NM
    Front Endocrinol (Lausanne); 2024; 15():1369268. PubMed ID: 38681767
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
    Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Persistent hypercalcaemia associated with two pathogenic variants in the
    Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
    Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
    Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
    Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.
    Colombo C; Ceruti D; Succi M; De Leo S; Trevisan M; Moneta C; Fugazzola L
    Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642580
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Current practices of craniospinal irradiation techniques in Turkey: a comprehensive dosimetric analysis.
    Şenkesen Ö; Tezcanlı E; Alkaya F; İspir B; Çatlı S; Yeşil A; Bezirganoglu E; Turan S; Köksal C; Güray G; Hacıislamoğlu E; Durmuş İF; Çavdar Ş; Aksu T; Çolak N; Küçükmorkoç E; Doğan M; Ercan T; Karaköse F; Alpan V; Ceylan C; Poyraz G; Nalbant N; Kınay Ş; İpek S; Kayalılar N; Tatlı H; Zhu M
    Radiat Oncol; 2024 Apr; 19(1):49. PubMed ID: 38627747
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-Term Follow-up of Patients With Autonomous thyroid Nodules Treated With Radioiodine.
    Moroto D; Torquato-Vieira ICO; Fiorin LB; Camacho CP; Castiglioni MLV; Maciel RMB; Furlanetto RP; Matsumura LK; Janovsky CCPS; Lindsey SC; Martins JRM
    Clin Nucl Med; 2024 Jun; 49(6):529-535. PubMed ID: 38619976
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An enzyme-free sensing platform for miRNA detection and in situ imaging in clinical samples based on DNAzyme cleavage-triggered catalytic hairpin assembly.
    Wang H; Shen M; Shen X; Liu J; Huang W; Jiang X; Liu H; Zeng S; Nan K; Cai S
    Biosens Bioelectron; 2024 Jul; 256():116279. PubMed ID: 38608496
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy.
    Nogi H; Ogiya A; Ishitobi M; Yamauchi C; Mori H; Shimo A; Narui K; Nagura N; Seki H; Sasada S; Sakurai T; Shien T;
    Breast Cancer; 2024 May; 31(3):507-518. PubMed ID: 38573438
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Lee-Saxton YJ; Palacardo F; Greenberg JA; Egan CE; Marshall TE; Tumati A; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    Surgery; 2024 Jan; 175(1):215-220. PubMed ID: 38563429
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PMFFNet: A hybrid network based on feature pyramid for ovarian tumor segmentation.
    Li L; He L; Guo W; Ma J; Sun G; Ma H
    PLoS One; 2024; 19(4):e0299360. PubMed ID: 38557660
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A comparison of the WHO 2004 and WHO 2017 thyroid tumor classifications.
    Patel N; Bavikar R; Lad YP; Singh M; Dharwadkar A; Viswanathan V
    J Cancer Res Ther; 2024 Jan; 20(1):311-314. PubMed ID: 38554339
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [The association between baseline TPOAb and/or TgAb positivity and thyroid immune-related adverse events in patients with malignancies following treatment with immune checkpoint inhibitors].
    Gao Y; Ye T; Wu LG; Xu Y; Wang X; Cheng XQ; Zhang YL; Wang YY; Fan XR; Zhao HT; Liu H; Chai XF; Zhang L; Wang MZ; Li NS; Lian XL
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):963-969. PubMed ID: 38514346
    [No Abstract]    [Full Text] [Related]  

  • 18. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
    Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
    Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Follow-up and Outcomes of 186 Patients With Follicular Cell-Derived thyroid cancer Seen at a Referral Center by One thyroidologist in 2015.
    Fatourechi V
    Endocr Pract; 2024 May; 30(5):450-455. PubMed ID: 38461879
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Does Radioactive Iodine treatment Damage the Lacrimal System?
    Gürez C; Ergül N
    Clin Nucl Med; 2024 Jun; 49(6):513-515. PubMed ID: 38451916
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 90.